Intermittent Fasting as a Neuroprotective Strategy: Gut–Brain Axis Modulation and Metabolic Reprogramming in Neurodegenerative Disorders
Nutrients · 09.07.2025 · 17 (14) · 2266
DOI: 10.3390/nu17142266 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 09.07.2025. Verfasst von Zaw Myo Hein und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, Ajman University, Ajman P.O. Box 346, United Arab Emirates. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Fasting, Brain, Brain-Gut Axis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ajman University.
Abstract (Originalsprache)
Intermittent fasting (IF) is emerging as a heterogeneous neurometabolic intervention with the possibility of changing the course of neurodegenerative diseases. Through the modulation of the gut–brain axis (GBA), cellular bioenergetics (or metabolic) reprogramming, and involvement in preserved stress adaptation pathways, IF influences a range of physiological mechanisms, including mitobiogenesis, autophagy, circadian rhythm alignment, and neuroinflammation. This review critically synthesises current preclinical and early clinical evidence illustrating IF’s capability to supplement synaptic plasticity and integrity, reduce toxic proteins (proteotoxic) burden, and rehabilitate glial and immune homeostasis across models of Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. The key players behind these effects are bioactive metabolites such as short-chain fatty acids (SCFA) and β-hydroxybutyrate (BHB), and molecular mediators such as brain-derived neurotrophic factor (BDNF). We feature the therapeutic pertinence of IF-induced changes in gut microbiota composition, immune response, and mitochondrial dynamics, and we discuss emerging approaches for merging IF into precision medicine frameworks. Crucial challenges include individual variability, protocol optimisation, safety in cognitively vulnerable populations, and the need for biomarker-guided, ethically grounded clinical trials. Finally, we propose IF as a scalable and flexible intervention that, when personalised and integrated with other modalities, may reframe neurodegeneration from a model of irreversible decline to one of modifiable resilience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, College of Medicine, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
- Department of Anatomy and Physiology, School of Basic Medical Sciences, Faculty of Medicine, University Sultan Zainal Abidin, Kuala Terengganu 20400, TGG, Malaysia.
- Department of Diagnostic and Allied Health Science, Faculty of Health and Life Sciences, Management and Science University, Shah Alam 40100, SEL, Malaysia.
- Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, SEL, Malaysia.
- Brain and Mental Health Research Advancement and Innovation Networks (PUTRA BRAIN), Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, SEL, Malaysia.
ORCID-Profile: Zaw Myo Hein, Suresh Kumar, Muhammad Zulfadli Mehat, Hafizah Abdul Hamid, Muhammad Danial Che Ramli, Che Mohd Nasril Che Mohd Nassir
Förderung
- Ajman University
Zitieren
APA
Hein, Z. M., Arbain, M. F. F., Kumar, S., Mehat, M. Z., Hamid, H. A., Che Ramli, M. D., & Che Mohd Nassir, C. M. N. (2025). Intermittent Fasting as a Neuroprotective Strategy: Gut–Brain Axis Modulation and Metabolic Reprogramming in Neurodegenerative Disorders. Nutrients, 17(14), 2266. https://doi.org/10.3390/nu17142266
Vancouver
Hein ZM, Arbain MFF, Kumar S, Mehat MZ, Hamid HA, Che Ramli MD, et al. Intermittent Fasting as a Neuroprotective Strategy: Gut–Brain Axis Modulation and Metabolic Reprogramming in Neurodegenerative Disorders. Nutrients. 2025;17(14):2266. doi:10.3390/nu17142266
BibTeX
@article{Hein2025,
author = {Hein, Zaw Myo and Arbain, Muhammad Faqhrul Fahmy and Kumar, Suresh and Mehat, Muhammad Zulfadli and Hamid, Hafizah Abdul and Che Ramli, Muhammad Danial and Che Mohd Nassir, Che Mohd Nasril},
title = {Intermittent Fasting as a Neuroprotective Strategy: Gut–Brain Axis Modulation and Metabolic Reprogramming in Neurodegenerative Disorders},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {14},
pages = {2266},
doi = {10.3390/nu17142266}
}
EUVIMED